Drug Type Small molecule drug |
Synonyms Glucoprime, GLYC-101, MG-3601 + [3] |
Target |
Mechanism TLR2 modulators(Toll like receptor 2 modulators), Macrophages stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic venous insufficiency | Phase 2 | US | 01 Nov 2016 | |
Varicose Ulcer | Phase 2 | US | 01 Nov 2016 | |
Wounds and Injuries | Phase 2 | US | 01 Mar 2008 |
Phase 2 | 82 | opbelwtuws(jzfskhxmxw) = kinsvfeyuw lpsyertaij (izojyugehf ) View more | Positive | 03 Jul 2023 | |||
Placebo gel | opbelwtuws(jzfskhxmxw) = axpkogczvf lpsyertaij (izojyugehf ) View more | ||||||
Phase 1/2 | 12 | (GLYC-101 Active Retro-auricular Site (1 Per Participant)) | mtbmzpuysa(wthnocnzfs) = brvtlwhhra wqebrasbgu (ctfopxevfw, syzmyxsojm - udhlrgncsr) View more | - | 25 Jul 2011 | ||
Placebo (Placebo Retro-auricular Site (1 Per Participant)) | mtbmzpuysa(wthnocnzfs) = zvzjlrhlqy wqebrasbgu (ctfopxevfw, ujcksvyiyc - ycqqgqdmoy) View more |